NGM Biopharmaceuticals Inc banner
N

NGM Biopharmaceuticals Inc
F:0IK

Watchlist Manager
NGM Biopharmaceuticals Inc
F:0IK
Watchlist
Price: 3.19 EUR 3.91%
Market Cap: €266.2m

Balance Sheet

Balance Sheet Decomposition
NGM Biopharmaceuticals Inc

Balance Sheet
NGM Biopharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
34
33
42
40
Cash Equivalents
34
33
42
40
Total Receivables
16
23
39
39
Accounts Receivables
15
21
30
31
Other Receivables
1
2
9
8
Inventory
41
48
108
157
Other Current Assets
5
3
3
4
Total Current Assets
96
107
192
245
PP&E Net
5
5
12
11
PP&E Gross
5
5
12
11
Accumulated Depreciation
4
6
8
11
Intangible Assets
26
36
59
73
Other Long-Term Assets
0
0
3
2
Total Assets
127
N/A
147
+16%
265
+80%
331
+25%
Liabilities
Accounts Payable
15
18
62
179
Accrued Liabilities
4
4
6
8
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
0
0
1
1
Other Current Liabilities
4
6
13
6
Total Current Liabilities
23
28
83
98
Long-Term Debt
2
1
6
5
Deferred Income Tax
6
8
10
10
Other Liabilities
0
4
7
8
Total Liabilities
31
N/A
40
+29%
106
+164%
121
+14%
Equity
Common Stock
45
45
65
1
Retained Earnings
51
62
94
177
Additional Paid In Capital
0
0
0
32
Total Equity
96
N/A
107
+12%
159
+49%
210
+32%
Total Liabilities & Equity
127
N/A
147
+16%
265
+80%
331
+25%
Shares Outstanding
Common Shares Outstanding
193
193
193
193